Xiangmei Chen

机构：Beijing Tongren Hospital, State Grid Corporation of China (China), Capital Medical University, Guangdong Pharmaceutical University, Chinese Academy of Sciences, State Administration of Traditional Chinese Medicine of the People's Republic of China, Chinese PLA General Hospital, National Clinical Research Center for Digestive Diseases, Institute of Acoustics, People's Liberation Army No. 150 Hospital, National Clinical Research, Chinese People's Liberation Army, University of Chinese Academy of Sciences, ImViA - Imagerie et Vision Artificielle, Chengdu University of Traditional Chinese Medicine · ORCID：0000-0001-5790-4789

发表论文 24 篇 · 总被引 676 次 · h-index 12

代表论文

• RETRACTED ARTICLE: LncRNA HOTAIR regulates HIF-1α/AXL signaling through inhibition of miR-217 in renal cell carcinoma (2017 · Cell Death and Disease · 被引 172)
• Sensitive and specific detection of clinical bacteria via vancomycin-modified Fe 3 O 4 @Au nanoparticles and aptamer-functionalized SERS tags (2018 · Journal of Materials Chemistry B · 被引 132)
• Targeted therapy of kidney disease with nanoparticle drug delivery materials (2024 · Bioactive Materials · 被引 91)
• U6 can be used as a housekeeping gene for urinary sediment miRNA studies of IgA nephropathy (2018 · Scientific Reports · 被引 49)
• Isoquercitrin Alleviates Diabetic Nephropathy by Inhibiting STAT3 Phosphorylation and Dimerization (2025 · Advanced Science · 被引 40)
• Ablation of lncRNA MIAT mitigates high glucose-stimulated inflammation and apoptosis of podocyte via miR-130a-3p/TLR4 signaling axis (2020 · Biochemical and Biophysical Research Communications · 被引 35)